The impact of inappropriate empirical antibiotic therapy (IEAT) on the outcome of severe infections due to extended spectrum beta-lactamases producers Enterobacteriaceae (ESBL-Ent) remains under debate. Current evidence is limited by study design and lacking confounder control. The main objective of this study was to define the outcome of severe infections due to ESBL-Ent according to clinical parameters and place of acquisition.
|Titolo:||Role of place of acquisition and inappropriate empirical antibiotic therapy on the outcome of extended-spectrum β-lactamase-producing Enterobacteriaceae infections|
CARRARA, ELENA (Corresponding)
|Data di pubblicazione:||2019|
|Appare nelle tipologie:||01.01 Articolo in Rivista|